Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.

Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I.

Arthritis Res Ther. 2011;13(6):R209. doi: 10.1186/ar3542. Epub 2011 Dec 16.

PMID:
22177419
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association between focal erosions and generalised bone loss in psoriatic arthritis.

Anandarajah AP, El-Taha M, Peng C, Reed G, Greenberg JD, Ritchlin CT.

Ann Rheum Dis. 2011 Jul;70(7):1345-7. doi: 10.1136/ard.2010.148452. Epub 2011 Feb 16. No abstract available.

PMID:
21325427
[PubMed - indexed for MEDLINE]
3.

Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry.

Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, Reed G, Chen R, Messing S, Kaukeinen K, Ritchlin CT.

J Rheumatol. 2010 Dec;37(12):2566-72. doi: 10.3899/jrheum.100483. Epub 2010 Sep 15.

PMID:
20843908
[PubMed - indexed for MEDLINE]
4.

The diagnosis and treatment of early psoriatic arthritis.

Anandarajah AP, Ritchlin CT.

Nat Rev Rheumatol. 2009 Nov;5(11):634-41. doi: 10.1038/nrrheum.2009.210. Epub 2009 Oct 6. Review.

PMID:
19806150
[PubMed - indexed for MEDLINE]
5.

Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies.

Anandarajah AP, Schwarz EM.

Adv Exp Med Biol. 2009;649:85-99. Review.

PMID:
19731622
[PubMed - indexed for MEDLINE]
6.

Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging.

Anandarajah AP, Ory P, Salonen D, Feng C, Wong RL, Ritchlin CT.

Ann Rheum Dis. 2010 Jan;69(1):206-9. doi: 10.1136/ard.2008.100149. Epub .

PMID:
19204015
[PubMed - indexed for MEDLINE]
7.

Role of RANKL in bone diseases.

Anandarajah AP.

Trends Endocrinol Metab. 2009 Mar;20(2):88-94. doi: 10.1016/j.tem.2008.10.007. Epub 2009 Jan 29.

PMID:
19185505
[PubMed - indexed for MEDLINE]
8.

The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.

Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, Haas-Smith SA, Ritchlin CT.

Ann Rheum Dis. 2008 Mar;67(3):296-301. Epub 2007 Oct 29.

PMID:
17967829
[PubMed - indexed for MEDLINE]
9.

Anti-RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications.

Anandarajah AP, Schwarz EM.

J Cell Biochem. 2006 Feb 1;97(2):226-32. Review.

PMID:
16240334
[PubMed - indexed for MEDLINE]
10.

Treatment update on spondyloarthropathy. From NSAIDs and DMARDs to anti-TNF-alpha agents.

Anandarajah AP, Ritchlin CT.

Postgrad Med. 2004 Nov;116(5):31-6, 39-40. Review.

PMID:
15580918
[PubMed - indexed for MEDLINE]
11.

Dynamic exercises in patients with rheumatoid arthritis.

Anandarajah AP, Schwarz EM.

Ann Rheum Dis. 2004 Nov;63(11):1359-61. No abstract available.

PMID:
15479884
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pathogenesis of psoriatic arthritis.

Anandarajah AP, Ritchlin CT.

Curr Opin Rheumatol. 2004 Jul;16(4):338-43. Review.

PMID:
15201594
[PubMed - indexed for MEDLINE]
13.

Etanercept in psoriatic arthritis.

Anandarajah AP, Ritchlin CT.

Expert Opin Biol Ther. 2003 Feb;3(1):169-77. Review.

PMID:
12718739
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk